Stay updated on DC-806 in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.

Latest updates to the DC-806 in Plaque Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study information regarding the efficacy and safety of DC-806 for plaque psoriasis, while retaining some identifiers and a description of the study's blinding process.SummaryDifference25%
- Check22 days agoChange DetectedThe web page has been updated to reflect the results of a clinical study on DC-806 for treating moderate to severe plaque psoriasis, including specific dosing information and results reporting dates. Key details about the study's design and participant outcomes have been clarified.SummaryDifference22%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to DC-806 in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.